Combined Chelation Treatment With Deferiprone and Deferoxamine in Thalassemia Major

PHASE4UnknownINTERVENTIONAL
Enrollment

65

Participants

Timeline

Start Date

May 31, 2004

Study Completion Date

June 30, 2005

Conditions
Beta-Thalassemia
Interventions
DRUG

deferiprone

Trial Locations (1)

09121

Ospedale Microcitemico, Via Jenner, Cagliari

Sponsors

Collaborators (1)

All Listed Sponsors
collaborator

CORDA, The Heart Charity

OTHER

collaborator

The Cooley's Anemia Foundation,

OTHER

collaborator

Apotex Inc.

INDUSTRY

collaborator

The UK Thalassemia Society

OTHER

lead

Royal Brompton & Harefield NHS Foundation Trust

OTHER